Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05885958 · ClinicalTrials.gov registry record · NA

Timing of Active Void Trials After Urogynecologic Procedures

A NA study of Postoperative Care and Urogynecology, sponsored by University of South Florida.

Completed
Registry status
NA
Development phase
231
Enrollment target
1
Study location

NCT05885958 is a NA study of Postoperative Care and Urogynecology that has completed, run by University of South Florida. The registered enrollment target is 231 participants, above the 90-participant average among 4 other Postoperative Care trials with a reported enrollment target (157% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05885958, a NA study of Postoperative Care and Urogynecology, has completed, sponsored by University of South Florida.

COMPLETED
Registry status
NA
Development phase
231 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn about active void trial pass rates in patients undergoing urogynecologic surgery. The main question it aims to answer is the comparison in pass rate during active void trial between women who are given 30 minutes versus 60 minutes to void following urogynecologic surgery. Patient will be randomized to two arms prior to scheduled surgery. During the active void trial, women will be allotted up to 30 minutes or up to 60 minutes to void depending on respective randomization.

Interventions

  • OTHER Time

Study Locations (1)

Florida

  • USF Urogynecology Clinic - Tampa

Trial Details

FieldValue
Enrollment Target 231 participants
Start Date 2023-07-03
Est. Completion 2025-06-05
Phase NA

Sponsor

University of South Florida

252 total trials

What the Registry Record Tells You About NCT05885958

The ClinicalTrials.gov registry entry for NCT05885958 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 231 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 90-participant average among 4 other Postoperative Care trials with a reported enrollment target (157% higher). The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Postoperative Care appearing as the primary indexed condition, and to 1 intervention - of which Time is the first listed.

NCT05885958 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05885958 about?

NCT05885958 is a clinical study titled "Timing of Active Void Trials After Urogynecologic Procedures". The goal of this clinical trial is to learn about active void trial pass rates in patients undergoing urogynecologic surgery. The main question it aims to answer is the comparison in pass rate during active void trial between women who are given 30 minutes versus 60 minutes to void following urogyne...

What is the current status of trial NCT05885958?

This trial is currently completed. It is a NA study. The enrollment target is 231 participants. The study started on 2023-07-03. Estimated completion is 2025-06-05.

What conditions does trial NCT05885958 study?

This clinical trial studies the following conditions: Postoperative Care, Urogynecology, Urinary Catheters.

What interventions are being tested in trial NCT05885958?

The interventions under investigation include: Time (OTHER).

Who is sponsoring clinical trial NCT05885958?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05885958 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Care

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.